Results 81 to 90 of about 6,489 (248)
Characterizing Cutaneous α‐Synuclein Deposition and Seeding Activity in Parkinson's Disease Subtypes
ABSTRACT Objective Cutaneous phosphorylated α‐synuclein (p‐syn) and α‐synuclein seeding activity are promising biomarkers for Parkinson's disease (PD), but their clinical value remains uncertain due to disease heterogeneity. This study evaluates these two biomarkers in PD patients to inform phenotype‐specific diagnosis and disease severity assessment ...
Yuting Jin +8 more
wiley +1 more source
Long‐Term Neurologic Exam Findings in People Diagnosed and Treated During Acute HIV Infection
ABSTRACT Objective Evaluate clinical and laboratory correlates of abnormal neurologic exam findings after acute HIV infection (AHI). Methods Participants from the RV254/SEARCH 010 cohort in Bangkok underwent standardized neurologic examinations at Weeks 0 (AHI), 12, 96, and 288 following antiretroviral therapy (ART).
Kathryn B. Holroyd +118 more
wiley +1 more source
The Multidimensional Mentalizing Questionnaire (MMQ)
The original (Italian) and translated versions of the Multidimensional Mentalizing Questionnaire (MMQ) are available here.
Eleonora Topino (9535184) +1 more
core +1 more source
Natural Frequencies of Levodopa‐Induced Dyskinesia in Parkinson's Disease
ABSTRACT Objectives Abnormal involuntary movements, known as dyskinesias, are common complications of levodopa treatment in patients with Parkinson's disease and can significantly impair quality of life. The underlying pathophysiology remains unclear, and current therapeutic options are limited.
Ioannis U. Isaias +3 more
wiley +1 more source
This practical guide on mentalization-based treatment (MBT) of personality disorders outlines the mentalizing model of borderline and antisocial personality disorders and how it translates into clinical treatment.
Fonagy, P, Bateman, A
core
Stage‐Dependent β‐Synuclein Links MRI and Cognitive Decline in Alzheimer's Disease
ABSTRACT Objective Synaptic degeneration drives cognitive decline in Alzheimer's disease (AD), but synaptic biomarkers are scarce. Brain‐enriched β‐synuclein emerged as a synaptic damage marker. We investigated its diagnostic, prognostic, and structural correlates across the AD continuum.
Ulaş Ay +15 more
wiley +1 more source
Mentalizing in clinical practice
Introduction -- Mentalizing -- Development -- Neurobiology -- The art of mentalizing -- Mentalizing interventions -- Treating attachment trauma -- Parenting and family therapy -- Borderline personality disorder -- Psychoeducation -- Social ...
Fonagy, Peter 1952- +2 more
core
ObjectivesMentalizing is a crucial factor in understanding antisocial behavior. The current study focuses on mapping mentalization within a population of patients with antisocial behavior (n = 108) and compares trait and state mentalizing.MethodsThree ...
De Wit-De Visser, Brenda +4 more
core +1 more source
Arterial Spin‐Labeling MRI at the Cortical‐CSF Interface: A Novel Biomarker in Alzheimer Disease
ABSTRACT Background/Objective Arterial spin‐labeling (ASL) MRI can measure perfusion signal adjacent to CSF spaces and may provide information regarding CSF‐adjacent water transport physiology. We developed an automated pipeline to extract cortical‐CSF interface (IF) perfusion for comparison between Alzheimer disease (AD) and cognitively normal ...
Mona Asghariahmadabad +22 more
wiley +1 more source
Parent-Child Mentalizing in Pediatric Epilepsy
Background: Child psychopathology involves inappropriate or biased attributions of others’ mental states (mentalizing), and parents’ assessment of their children’s mentalizing significantly predicts the latter’s psychosocial outcomes.
Gannon, Emily +2 more
core +4 more sources

